Short answer: Your age sets the usual breast-screening interval; a high-risk history may move the start earlier or add MRI. For people without symptoms who fit its average-risk guidance, the US Preventive Services Task Force (USPSTF) recommends a mammogram every two years from 40 through 74.[1] Japan’s national cancer center advises women to have mammograms every two years from 40.[2] The American Cancer Society (ACS) calls for yearly screening at 45–54 and, for certain high-risk women, yearly mammography plus MRI from around 30; these are US guidelines, not Japanese municipal rules.[3]
Under 40: does risk call for an earlier plan?
The USPSTF recommendation gives no routine schedule for average-risk people under 40; that is not a recommendation against screening everyone younger than 40. If you have a known high-risk variant or a history of high-dose chest radiation at a young age, ask about a risk-specific plan rather than waiting for the usual starting age. The ACS high-risk criteria are explained below.[1][3]

Ages 40–54: how often?
The US organizations differ on frequency. At average risk, the USPSTF says every two years. The ACS offers women aged 40–44 the choice to start yearly mammograms and recommends yearly screening at 45–54. If you are 48, for example, ask which US schedule you and your clinician are following rather than assuming every guideline says the same thing.[1][3]
Japan’s population program uses a questionnaire and mammography every two years for women from 40; ultrasound or a breast exam alone is not a routine substitute. If your result says further examination is needed, arrange diagnostic follow-up rather than waiting for the next two-year screen. The site’s overview of health screening in Japan puts breast screening alongside other age-based checks; the national cancer center, not that site page, is the source for this breast-screening advice.[4][2]
Age 55 and older: when does the schedule change?
Through 74, the USPSTF continues to advise a mammogram every two years. The ACS lets women 55 and older continue yearly mammograms or switch to every two years while they remain in good health and have a life expectancy of at least 10 years. For those 75 and older, the USPSTF says evidence is insufficient to weigh benefits against harms; it does not set an automatic stopping age. The cited Japanese advice does not give the US age-74 cutoff, so check your local program’s rules.[1][3][2]
Which risks change the usual schedule?
The USPSTF’s US average-risk schedule covers people assigned female at birth, including those with dense breasts or a parent, sibling or child with breast cancer. It does not cover people with a known high-risk genetic syndrome, previous breast cancer, a high-risk biopsy finding or high-dose chest radiation at a young age.[1]
Under ACS guidance, examples of women who may need yearly MRI alongside mammography include those with a BRCA1 or BRCA2 variant, chest radiation before 30, or a family-history-based lifetime breast cancer risk around 20%–25% or higher. One relative with breast cancer does not automatically meet that MRI threshold. Ask whether formal risk assessment or genetic counseling is appropriate. If you have already had breast cancer, ask your treating doctor about follow-up rather than using a routine population timetable.[3][2]
Do dense breasts mean you need MRI?
Density alone does not remove you from the USPSTF age-based mammogram schedule. After a normal mammogram, the task force finds too little evidence to recommend for or against routine extra ultrasound or MRI.[1] In a Dutch trial of 40,373 women aged 50–75 with extremely dense breasts and normal mammograms, an MRI invitation was compared with mammography alone. Over two years, cancers found between scheduled screens occurred at 2.5 versus 5.0 per 1,000 screenings. Of those invited, 59% had MRI; among those who had MRI, the false-positive rate was 79.8 per 1,000 MRI screenings. The trial studied interval cancers, not breast-cancer deaths. It does not set a routine MRI schedule for other density groups or Japan.[5]
What changes if screening starts at 40 instead of 50?
Six US models compared digital breast tomosynthesis mammograms every two years from 40 through 74 with the same method and interval from 50 through 74. Starting at 40 was estimated to avert 1.3 more breast-cancer deaths per 1,000 women over a lifetime—the median of the six models’ within-model differences. Estimated false-positive callbacks were 1,376 versus 873 per 1,000, respectively; the same person could be called back more than once. The models assumed full screening attendance. These are US lifetime estimates, not clinical-trial outcomes, Japan-specific predictions or a yearly-versus-two-year comparison.[6][1]
A callback does not mean cancer, but it can lead to more imaging or a biopsy. Screening can also miss a cancer, detect one that would never have caused harm (overdiagnosis), or involve radiation exposure. Discuss both the possible benefit and these harms when deciding how to apply a schedule to your circumstances.[1]
What should you check before booking?
Check the date and result on your last mammogram report. If it mentions dense tissue, bring the wording of that finding rather than assuming it means extremely dense breasts or an automatic MRI. Note any earlier breast biopsy or cancer. For relatives with breast cancer on either side of your family, write down who was affected and their ages at diagnosis; ask whether your history calls for formal risk assessment rather than simply moving the date of your next mammogram.[1][3] A new lump or bloody nipple discharge calls for prompt medical evaluation, not a routine screening appointment.[2]
Planning a visit in Japan? You can ask the international patient team a non-urgent question about organizing your records. Screening eligibility and medical decisions remain with the relevant program and clinician.
For this article, we checked the original US guidance, Japan’s cancer-center pages, and the published trial and model results cited above. We did not observe patient screening visits or assess individual cases. This article has not received an article-specific physician review. It offers general information, not an individual screening plan.
Sources
- US Preventive Services Task Force. Breast Cancer: Screening. Final recommendation, April 30, 2024.
- National Cancer Center Japan, Cancer Information Service. Breast cancer screening (Japanese).
- American Cancer Society. Breast cancer screening recommendations.
- National Cancer Center Japan, Cancer Information Service. Breast cancer: Prevention and screening (Japanese). Reviewed March 28, 2025.
- Bakker MF et al. Supplemental MRI Screening for Women with Extremely Dense Breast Tissue. New England Journal of Medicine. 2019;381:2091–2102. doi:10.1056/NEJMoa1903986.
- Trentham-Dietz A et al. Breast Cancer: Screening, modeling study. JAMA, April 30, 2024.